EPR insider files to sell 7,500 shares under Form 144

A shareholder of EPR has filed a Form 144 notice to potentially sell 7,500 shares of common stock through UBS Financial Services on the NYSE, with an indicated aggregate market value of $389,625.00.

Rhea-AI Filing Summary

A shareholder of EPR has filed a Form 144 notice to potentially sell 7,500 shares of common stock through UBS Financial Services on the NYSE, with an indicated aggregate market value of $389,625.00. The issuer had 76,140,341 shares outstanding at the time of the notice, which shows the planned sale is small relative to the total share count.

The 7,500 shares to be sold were acquired on 12/31/2021 as compensation from the issuer. Over the past three months, the same selling account completed three prior sales of 7,500 common shares each, with gross proceeds of $435,864.75 on 10/01/2025, $400,106.25 on 09/02/2025, and $369,095.25 on 11/03/2025. The signer represents that they are not aware of undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing related to EPR disclose?

The Form 144 discloses that a shareholder plans to sell 7,500 shares of EPR common stock on the NYSE through UBS Financial Services, with an indicated aggregate market value of $389,625.00.

How many EPR shares are outstanding compared with the planned Form 144 sale?

The issuer had 76,140,341 common shares outstanding when the notice was filed, while the Form 144 covers a planned sale of 7,500 shares.

When and how were the EPR shares in this Form 144 acquired?

The 7,500 EPR common shares covered by the Form 144 were acquired on 12/31/2021 as compensation from the issuer, with payment made on the same date.

What recent EPR share sales has the same seller reported in the last three months?

Over the past three months, the same account sold 7,500 EPR common shares on each of 09/02/2025, 10/01/2025, and 11/03/2025, for gross proceeds of $400,106.25, $435,864.75, and $369,095.25, respectively.

What representation does the seller make in this EPR Form 144 notice?

By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Which broker is handling the planned EPR share sale under Form 144?

The planned sale of 7,500 EPR common shares is to be executed through UBS Financial Services, Inc. at its New York office, with trading on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/01/2025 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001722346
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EPR PROPERTIES
SEC File Number	001-13561
Address of Issuer	909 WALNUT STREET SUITE 200 KANSAS CITY MISSOURI 64106
Phone	8164721700
Name of Person for Whose Account the Securities are To Be Sold	Zimmerman Gregory E
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc Eleven Madison Avenue 4th Floor New York NY 10010	7500	389625.00	76140341	12/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2021	Compensation	Issuer			7500	12/31/2021	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Gregory Zimmerman Revocable Trust Amended and Reinstated 6-2-2015 909 Walnut Street, Suite 200 Kansas City MO 64106	Common	10/01/2025	7500	435864.75
Gregory Zimmerman Revocable Trust Amended and Reinstated 6-2-2015 909 Walnut Street Suite 200 Kansas City MO 64106	Common	09/02/2025	7500	400106.25
Gregory Zimmerman Revocable Trust Amended and Reinstated 6-2-2015 909 Walnut Street Suite 200 Kansas City MO 64106	Common	11/03/2025	7500	369095.25

144: Remarks and Signature

Remarks	The shares covered by this filing are being sold under the Gregory Zimmerman Revocable Trust Amended and Reinstated 6-2-2015.
Date of Notice	12/01/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc., as attorney-in-fact for Gregory Zimmerman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)